Vir Biotechnology VIR
NASDAQ VIR
$11.29 +0.11 (+0.98%)
At close: Oct 1, 2026 · 4:00 PM EDT

Vir Biotechnology (VIR) Accumulated Expenses (2018 - 2026)

Updated

Vir Biotechnology (VIR) recorded Accumulated Expenses of $77.21 million in Q2 2026, down 6.6% from $82.66 million a year earlier but up 13.4% from the prior quarter.

Analysis

Vir Biotechnology (VIR) Accumulated Expenses (2018 - 2026) Analysis & Trends

At the end of FY2025, Vir Biotechnology reported Accumulated Expenses of $83.01 million, down 15.7% from FY2024.

  • Annual Accumulated Expenses has declined for three straight years, though with a five-year compound annual growth rate of 1.5% (FY2020 to FY2025).
  • Across earlier years, Accumulated Expenses came in at $98.52 million in FY2024 (-5.5%), $104.22 million in FY2023 (-78.7%), $489.09 million in FY2022 (+106.8%) and $236.51 million in FY2021 (+207.4%).
  • Quarterly Accumulated Expenses has ranged from $64.85 million in Q3 2021 to $577.67 million in Q1 2022 over the past five years.
  • On a year-over-year basis, Accumulated Expenses has declined for four consecutive quarters, with an average decline of 8.9% over the last eight quarters.
  • Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 724.4% in Q1 2022, against a decline of 84.2% in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $68.11 million (Q1 2026), $83.01 million (Q4 2025) and $68.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Vir Biotechnology 1.89 Bn 1.89 Bn 238.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 77.21 Mn
Mar 31, 2026 68.11 Mn
Dec 31, 2025 83.01 Mn
Sep 30, 2025 68.38 Mn
Jun 30, 2025 82.66 Mn
Mar 31, 2025 104.13 Mn
Dec 31, 2024 98.52 Mn
Sep 30, 2024 94.66 Mn
Jun 30, 2024 75.32 Mn
Mar 31, 2024 72.26 Mn
Dec 31, 2023 104.22 Mn
Sep 30, 2023 146.11 Mn
Jun 30, 2023 197.58 Mn
Mar 31, 2023 455.92 Mn
Dec 31, 2022 489.09 Mn
Sep 30, 2022 282.62 Mn
Jun 30, 2022 354.09 Mn
Mar 31, 2022 577.67 Mn
Dec 31, 2021 236.51 Mn
Sep 30, 2021 64.85 Mn
API Access

Vir Biotechnology Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VIR&period=max&api_key=YOUR_API_KEY